Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

C4 Therapeutics (CCCC) Tax Provisions: 2019-2024

Historic Tax Provisions for C4 Therapeutics (CCCC) over the last 1 years, with Dec 2024 value amounting to $131,000.

  • C4 Therapeutics' Tax Provisions fell 52.71% to $131,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year increase of 30.13%. This contributed to the annual value of $131,000 for FY2024, which is 89.77% down from last year.
  • According to the latest figures from Q4 2024, C4 Therapeutics' Tax Provisions is $131,000, which was down 52.71% from $277,000 recorded in Q4 2023.
  • In the past 5 years, C4 Therapeutics' Tax Provisions ranged from a high of $1.0 million in Q3 2023 and a low of -$168,000 during Q2 2020.
  • Moreover, its 2-year median value for Tax Provisions was $277,000 (2023), whereas its average is $470,333.
  • Data for C4 Therapeutics' Tax Provisions shows a maximum YoY slumped of 125.69% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows C4 Therapeutics' Tax Provisions stood at -$124,000 in 2020, then reached $277,000 in 2023, then crashed by 52.71% to $131,000 in 2024.
  • Its Tax Provisions stands at $131,000 for Q4 2024, versus $277,000 for Q4 2023 and $1.0 million for Q3 2023.